MDCX · Company research
Medicus Pharma Ltd. Common Stock (MDCX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| 409,411 directly owned shares are only part of an amended Medicus Pharma (MDCX) stake report. - Stock Titan | 409,411 directly owned shares are only part of an amended Medicus Pharma (MDCX) stake report. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| Medicus Pharma (MDCX) Tumbles 22.26% to $3.58 as Key Support Comes Into Focus - Gamma Squeeze - https://www.siam.in/ | Medicus Pharma (MDCX) Tumbles 22.26% to $3.58 as Key Support Comes Into Focus - Gamma Squeeze https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 13, 2026 | neutral | 0 | 0.6 |
| Medicus Pharma Ltd (MDCX) Stock Price, Quote, News & History - Benzinga | Medicus Pharma Ltd (MDCX) Stock Price, Quote, News & History Benzinga | View source ↗ | Benzinga | Oct 12, 2026 | neutral | 0 | 0.6 |
| Medicus Pharma Ltd. (MDCX) stock price, news, quote and history - Yahoo Finance UK | Medicus Pharma Ltd. (MDCX) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 9, 2026 | neutral | 0 | 0.6 |
| The FDA authorized a planned skin-cancer study for people with a rare inherited condition. - Stock Titan | The FDA authorized a planned skin-cancer study for people with a rare inherited condition. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Medicus Pharma (MDCX) Shares Fall 24% After Hours: Here's Why - Benzinga | Medicus Pharma (MDCX) Shares Fall 24% After Hours: Here's Why Benzinga | View source ↗ | Benzinga | Oct 8, 2026 | neutral | 0 | 0.6 |
| MDCX Stock Price, Quote & Chart - ChartMill | MDCX Stock Price, Quote & Chart ChartMill | View source ↗ | ChartMill | Sep 29, 2026 | neutral | 0 | 0.6 |
| A prostate cancer plan could reduce enrollment from about 1,500 to about 600 patients if FDA agrees. - Stock Titan | A prostate cancer plan could reduce enrollment from about 1,500 to about 600 patients if FDA agrees. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Medicus Pharma Shifts SkinJect Focus to Gorlin Syndrome | MDCX Stock News - Stock Titan | Medicus Pharma Shifts SkinJect Focus to Gorlin Syndrome | MDCX Stock News Stock Titan | View source ↗ | Stock Titan | Sep 21, 2026 | neutral | 0 | 0.6 |
| MDCX 8-K Filings - Medicus Pharma Ltd. SEC 8-K - Stock Titan | MDCX 8-K Filings - Medicus Pharma Ltd. SEC 8-K Stock Titan | View source ↗ | Stock Titan | Sep 14, 2026 | neutral | 0 | 0.6 |
| FDA authorizes the next study of a skin cancer patch - Stock Titan | FDA authorizes the next study of a skin cancer patch Stock Titan | View source ↗ | Stock Titan | Sep 10, 2026 | neutral | 0 | 0.6 |
| Price to book forward of Medicus Pharma Ltd. – NASDAQ:MDCX - TradingView | Price to book forward of Medicus Pharma Ltd. – NASDAQ:MDCX TradingView | View source ↗ | TradingView | Aug 9, 2026 | neutral | 0 | 0.6 |
| Is Medicus Pharma Ltd. (MDCX) Stock Gaining Momentum With Innovative Skin Cancer Treatment Technology? - Yahoo Finance | Is Medicus Pharma Ltd. (MDCX) Stock Gaining Momentum With Innovative Skin Cancer Treatment Technology? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
| MDCX Forecast — Price Target — Prediction for 2027 - TradingView | MDCX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook - Yahoo Finance | Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook Yahoo Finance | View source ↗ | Yahoo Finance | May 19, 2026 | neutral | 0 | 0.6 |
| Lockheed Martin MDCX Powers MQ-25A Flight And Reshapes LMT Valuation Narrative - Yahoo Finance | Lockheed Martin MDCX Powers MQ-25A Flight And Reshapes LMT Valuation Narrative Yahoo Finance | View source ↗ | Yahoo Finance | Apr 27, 2026 | neutral | 0 | 0.6 |
| MDCX Navigates Uncertain Waters Amid Recent Earnings and Market Trends - Timothy Sykes | MDCX Navigates Uncertain Waters Amid Recent Earnings and Market Trends Timothy Sykes | View source ↗ | Timothy Sykes | Mar 5, 2026 | neutral | 0 | 0.6 |
| MDCX Should I Buy - Intellectia AI | MDCX Should I Buy Intellectia AI | View source ↗ | Intellectia AI | Feb 14, 2026 | neutral | 0 | 0.6 |
| Maxim Group Reaffirms Buy on Medicus Pharma Ltd (MDCX) With $20 Target - Yahoo Finance | Maxim Group Reaffirms Buy on Medicus Pharma Ltd (MDCX) With $20 Target Yahoo Finance | View source ↗ | Yahoo Finance | Nov 25, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.